European Journal of Nuclear Medicine

, Volume 23, Issue 7, pp 741–747 | Cite as

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

  • Masayuki Sasaki
  • Yuichi Ichiya
  • Yasuo Kuwabara
  • Yuko Akashi
  • Tsuyoshi Yoshida
  • Toshimitsu Fukumura
  • Sadayuki Murayama
  • Teruyoshi Ishida
  • Kenji Sugio
  • Kouji Masuda
Original Article

Abstract

We evaluated the usefulness of fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) in the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer and then compared the findings with the results of X-ray CT by region based on the histological diagnoses. We examined 29 patients with non-small cell lung cancer. One hundred and thirty-two mediastinal lymph nodes were surgically removed and the histological diagnoses were confirmed. FDG PET images, including 146 mediastinal regions, were visually analysed and the mediastinal lymph nodes were scored as positive when the FDG uptake was higher than that in the other mediastinal structures. On the X-ray CT scans, any mediastinal lymph nodes with a diameter of 10 mm or larger were scored as positive. All three examinations were successfully performed on 71 regions. For FDG PET, we found a sensitivity of 76%, a specificity of 98% and an accuracy of 93%. On the other hand, for X-ray CT a sensitivity of 65%, a specificity of 87% and an accuracy of 82% were observed. A significant difference was observed in respect of both specificity and accuracy (P<0.05). Based on the above findings, FDG PET is suggested to be superior to X-ray CT when used for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer.

Key words

Lung cancer Mediastinal lymph node Fluorine-18-fluoro-2-deoxy-d-glucose Positron emission tomography 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, Tatsuzawa Y, Iwa T, Suzuki M, Takashima T. Aggressive surgical intervention in N2 non-small cell cancer of the lung.Ann Thorac Surg 1991; 51: 253–261.Google Scholar
  2. 2.
    Staples CA, Müller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.Radiology 1988; 167: 367–372.Google Scholar
  3. 3.
    Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, McNeil BJ. CT and MR imaging in staging nonsmall cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group.Radiology 1991; 178: 705–713.Google Scholar
  4. 4.
    McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JAO, Moore EH, Wain JC, Mathisen DJ, Grillo H. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.Radiology 1992; 182: 319–323.Google Scholar
  5. 5.
    Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.Radiology 1994; 191; 371–377.Google Scholar
  6. 6.
    Musset D, Grenier P, Carette MF, Frija G, Hauuy MP, Desbleds MT, Girard P, Bigot JM, Lallemand D. Primary lung cancer staging: prospective comparative study of MR imaging with CT.Radiology 1986; 160: 607–611.Google Scholar
  7. 7.
    Poon PY, Bronskill MJ, Henkelman RM, Rideout DF, Shulman HS, Weisbrod GL, Steinhardt MI, Dunlap HJ, Ginsberg RJ, Feld R, Sutcliffe SB, Williams JI. Mediastinal lymph node metastases from bronchogenic carcinoma: detection with MR imaging and CT.Radiology 1987; 162: 651–656.Google Scholar
  8. 8.
    Nolop KB, Rhodes CG, Brudin LH, Beaney RP, Krausz T, Jones T, Hughes JMB. Glucose utilization in vivo by human pulmonary neoplasms.Cancer 1987; 60: 2682–2689.Google Scholar
  9. 9.
    Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T. Differential diagnosis of lung tumor with positron emission tomography: a prospective study.J Nucl Med 1990; 31: 1927–1933.Google Scholar
  10. 10.
    Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, Phalen JJ, Sunderland JJ, Frick MP. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-d-glucose.Radiology 1992; 184: 441–444.Google Scholar
  11. 11.
    Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.J Nucl Med 1991; 32: 1655–1660.Google Scholar
  12. 12.
    The Japan Lung Cancer Society. General rules for clinical and pathological records of lung cancer. Tokyo: Kanahara, 1987.Google Scholar
  13. 13.
    Kanno I, Miura S, Yamamoto S, Iida H, Murakami M, Takahashi K, Uemura K. Design and evaluation of a positron emission tomogram: Headtome III.J Comput Assist Tomogr 1985; 9: 931–939.Google Scholar
  14. 14.
    Akashi Y, Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Fukumura T, Masuda K. The partial volume effect correction for pulmonary mass lesions using68Ga/68Ge transmission scan in PET study. [in Japanese].Jpn J Nucl Med 1994; 31: 1511–1517.Google Scholar
  15. 15.
    Friedman PJ. Lung cancer: update on staging classification.AJR 1988; 150: 261–264.Google Scholar
  16. 16.
    Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, Oster ZH, Sacker DF, Shine CY, Turner H, Wan C-N, Wolf AP, Zabinski SV. A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (F-18): non-toxic tracer for rapid tumor detection.J Nucl Med 1980; 21: 670–675.Google Scholar
  17. 17.
    Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Masuda K. High [18F]fluorodeoxyglucose uptake in abdominal abscess: a PET study.J Comput Assist Tomogr 1989; 13: 829–831.Google Scholar
  18. 18.
    Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Masuda K. Ringlike uptake of [18F]FDG in brain abscess: a PET study. J Comput Assisst Tomogr 1990; 14: 486–487.Google Scholar
  19. 19.
    Brudin LH, Valind S-O, Rhodes CG, Pantin CF, Sweatman M, Jones T, Hughes JMB. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.Eur J Nucl Med 1994; 21: 297–305.Google Scholar
  20. 20.
    Lewis PJ, Salama A. Uptake of fluorine-18-deoxyglucose in sarcoidosis.J Nucl Med 1994; 35: 1647–1649.Google Scholar
  21. 21.
    Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.J Nucl Med 1995; 36: 1301–1306.Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Masayuki Sasaki
    • 1
  • Yuichi Ichiya
    • 1
  • Yasuo Kuwabara
    • 1
  • Yuko Akashi
    • 1
  • Tsuyoshi Yoshida
    • 1
  • Toshimitsu Fukumura
    • 1
  • Sadayuki Murayama
    • 1
  • Teruyoshi Ishida
    • 2
  • Kenji Sugio
    • 2
  • Kouji Masuda
    • 1
  1. 1.Department of Radiology, Faculty of MedicineKyushu UniversityFukuokaJapan
  2. 2.Department of Surgery II, Faculty of MedicineKyushu UniversityFukuokaJapan
  3. 3.Department of Radiology, Faculty of MedicineKyushu UniversityFukuokaJapan

Personalised recommendations